Skip to main content
. 2014 Mar 5;2(3):218–229. doi: 10.1002/fsn3.92

Figure 2.

Figure 2

Resveratrol treatment attenuates the adverse cardiac remodeling and contractile dysfunction in TAC-induced heart failure. Echocardiography was performed at the indicated time points in the sham, TAC, and TAC + resveratrol groups of mice. (A) LVID;d. (B) LVPW;d. (C) EF. (D) FS. Values are expressed as the mean ± SD. *P < 0.05 was considered statistically significant.